Italian
Principles of Anticancer Drug Development
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Basic Biostatistics for the Clinical Trialist
-
Altmetric BadgeChapter 2 Fundamental Concepts in Clinical Pharmacology
-
Altmetric BadgeChapter 3 Bioanalytical Methods in Clinical Drug Development
-
Altmetric BadgeChapter 4 Preclinical Models for Anticancer Drug Development
-
Altmetric BadgeChapter 5 Phase I Clinical Trials with Anticancer Agents
-
Altmetric BadgeChapter 6 Phase II Trials with Anticancer Agents
-
Altmetric BadgeChapter 7 Phase III Clinical Trials with Anticancer Agents
-
Altmetric BadgeChapter 8 Pharmacokinetic Studies in Early Anticancer Drug Development
-
Altmetric BadgeChapter 9 Pharmacodynamic Studies in Early Phase Drug Development
-
Altmetric BadgeChapter 10 Prediction of Antitumor Response
-
Altmetric BadgeChapter 11 Imaging Studies in Anticancer Drug Development
-
Altmetric BadgeChapter 12 Role of the US Food and Drug Administration in Cancer Drug Development
-
Altmetric BadgeChapter 13 Early Clinical Trials with Cytotoxic Agents
-
Altmetric BadgeChapter 14 Challenges and Successes in Developing Effective Anti-angiogenic Agents
-
Altmetric BadgeChapter 15 Targeted Therapeutics in Cancer Treatment
-
Altmetric BadgeChapter 16 Cancer Chemoprevention
-
Altmetric BadgeChapter 17 Combined Modality Therapy in Cancer Management
-
Altmetric BadgeChapter 18 Cancer Vaccines
-
Altmetric BadgeChapter 19 Optimising the Development of Antibodies as Treatment for Cancer
-
Altmetric BadgeChapter 20 Oligonucleotide Therapeutics
-
Altmetric BadgeChapter 21 Anticancer Drug Development in Pediatric Patients
-
Altmetric BadgeChapter 22 Clinical Trials in Special Populations
-
Altmetric BadgeChapter 23 NCI-Sponsored Clinical Trials